SEMA3B-AS1 suppresses colorectal carcinoma progression by inhibiting Semaphorin 3B-dependent VEGF signaling pathway activation.
Wang YQ, Chen H, Xu S, Liao CR, Xu A, Han Y, Yang MH, Zhao L, Hu SS, Wang L, Li QY, Zhan LY, Ding YQ, Wang S.
Wang YQ, et al. Among authors: wang l, wang s.
MedComm (2020). 2023 Sep 10;4(5):e365. doi: 10.1002/mco2.365. eCollection 2023 Oct.
MedComm (2020). 2023.
PMID: 37701532
Free PMC article.